Live News Categoriesequity

TransThera Sciences (Nanjing), Inc. (2617.HK) News

Track canonical SquawkNews coverage tagged to 2617.HK, TransThera Sciences (Nanjing), Inc.. This hub brings together deduplicated headlines about hkse, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 2617.HK Asset equity Sector Markets 90 days 1 Last 10.03 Updated Sep 18, 2026, 03:37 PM UTC Open live news feed

L BRIEF — Transthera Sciences (Nanjing) Says Yochanra (Tinengotinib) Included In CSCO Guidelines Sept 18 (Reuters) — TransThera Sciences (Nanjing): Yochanra (Tinengotinib) Included In Csco Guidelines For Advanced Biliary Tract Cancers Further company coverage: 2617.HK (Reuters.Briefs@thomsonreuters.com;) NEWS | Sep 18, 2026, 03:37 PM UTC